IP Library › Granted Patent US 11,992,523
Granted Patent B2
US 11,992,523 · App. 17/850,706 · Granted May 28, 2024

Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteins

Inventors: Gary J. Nabel (Chestnut Hill, MA); Wataru Akahata (Kensington, MD); Srinivas Rao (Columbia, MD)
Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
A61K39/12C12N7/00C12N7/045A61K2039/5258A61K2039/55566C12N2740/16043C12N2770/36123C12N2770/36134Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,992,523
App. No.
17/850,706
Granted
May 28, 2024
Kind
B2
Abstract

The invention features compositions and methods for the prevention or treatment of one or more strains of Chikungunya virus, as well as other alphavirus-mediated diseases.

Claims (6)

1. A method for producing a virus-like particle, comprising:

expressing in a cell one or more polynucleotides encoding Chikungunya virus (CHIKV) strain 37997 structural proteins under conditions for self-assembly of the CHIKV strain 37997 structural proteins to form a virus-like particle, wherein the CHIKV strain 37997 structural proteins comprise at least CHIKV capsid (C) protein, CHIKV E2 protein, and CHIKV E1 protein, and

wherein the cell does not express polynucleotides encoding CHIKV non-structural proteins.

2. The method of claim 1 , wherein the CHIKV strain 37997 structural proteins comprise at least CHIKV capsid (C) protein, CHIKV E3 protein, CHIKV E2 protein, CHIKV 6K protein, and CHIKV E 1 protein.

3. The method of claim 1 , wherein the one or more polynucleotides encode a polyprotein comprising the CHIKV capsid (C) protein, a CHIKV E3 protein, the CHIKV E2 protein, a CHIKV 6K protein, and the CHIKV E1 protein.

4. The method of claim 1 , further comprising isolating the virus-like particle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: NABEL, GARY J.; AKAHATA, WATARU; RAO, SRINIVAS S.
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 060445/0898 →
Continuity (6)
Continuation 16520113 · Jul 23, 2019
Division 15145483 · May 3, 2016
Division 13131287
Provisional Application 61201118 · Dec 5, 2008
Provisional Application 61118206 · Nov 26, 2008
Related Publication 20230025038A1 · Jan 26, 2023